查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439264

心臟辅助设备 - 全球市场考量、竞争格局、市场预测 (2030)

Cardiac Assist Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球心臟辅助设备市场规模将于2023年达到28.9亿美元，到2030年将达到62.3亿美元，预计2024-2030年期间复合年增长率为13.70%。 冠状动脉疾病患病率上升、新疗法的增长、医疗器械的可负担性、新兴国家心臟辅助器械的普及和接受度不断提高以及医疗器械的创新和进步推动了对心臟辅助器械的需求。这是一个促成因素。

心臟辅助设备的市场动态

心臟移植被广泛认为是世界各地末期心臟衰竭患者的第一治疗选择。 由于缺乏可供移植的器官，接受移植的患者比例有限。 最新统计数据显示，等待心臟移植的患者人数在短短五年内增加了一倍以上。 然而，捐赠者短缺、等待时间长以及越来越多的不稳定患者正在推动心臟辅助设备的发展。

心臟辅助装置 (CAD) 是一种机械泵，可与心臟配合使用，以提高其有效性并维持全身最佳的血流。 心臟辅助装置用于治疗末期心臟衰竭，取决于个人的需求。 由于心臟捐赠者短缺，临时心臟辅助装置被用来为个人提供长期援助。

根据美国心臟协会报告（2020），随着人口老化，心臟衰竭的盛行率持续增加。 老年患者数量的增加预计将改变医疗保健服务并增加对心臟辅助设备的需求。 根据最近的一项研究《2020年全球人口老化报告》（联合国，2020），人口老化正以惊人的速度成长。 2020年，全球65岁以上人口约为7.27亿人。 到 2050 年，此类患者的数量预计将增加一倍，达到 15 亿。 老年人更容易患心血管疾病，这增加了对心臟辅助设备的需求，并刺激了心臟辅助设备市场。

此外，公司正在增加基本医疗器材产品的产量。 例如，2022 年 8 月，FDA 授予 Abiomed 的 Impella ECP 可扩展经皮心臟帮浦突破性医疗器材称号。 这项指定意味着 FDA 将优先考虑 Impella ECP 的监管审查流程，包括设计迭代、临床试验方案和上市前批准 (PMA) 备案。

因此，此类措施预计将有助于市场和患者治疗，并推动心臟辅助设备市场的成长。

然而，植入式装置的高治疗成本和安全限制可能会对心臟辅助设备市场的成长产生一定的限制。

心臟辅助设备市场区隔分析

在心臟辅助设备市场的产品领域，心室辅助设备预计在预测期内将占据重要份额。 这主要是由于与 LVAD 相关的技术进步、益处和应用、器官捐赠者的缺乏以及全球心臟衰竭盛行率的增加。

LVAD 旨在透过恢復正常血流来治疗严重心臟衰竭患者。 在心臟衰竭患者体内植入 LVAD 可以挽救生命，并为器官移植赢得时间。

LVAD 高度可靠，并具有内建安全系统。

植入 LVAD 后，患者的健康状况有所改善，并且能够恢復/恢復运动和其他日常活动。

LVAD为严重心臟衰竭患者提供了中长期治疗方案。 此外，政府机构的援助和有利的报销方案预计将提振一些国家心臟辅助设备市场的前景。

因此，上述所有因素预计将推动该细分市场的成长。

本报告提供了全球心臟辅助设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章心臟辅助设备市场报告简介

第二章心臟辅助设备市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章心臟辅助器材市场主要因素分析

  • 推动心臟辅助设备市场的因素
    • 冠状动脉疾病的盛行率不断上升
    • 新疗法的成长
    • 缺乏心臟捐赠者
  • 心臟辅助设备市场的限制与挑战
    • 帮浦的成本高
    • 发展中国家的低还款状况
  • 心臟辅助设备市场机遇
    • 心臟辅助装置的普及率和接受度不断提高
    • 开发非侵入式、紧凑型和先进的设备

第 5 章心臟辅助装置的波特五力分析

第六章心臟辅助器材市场布局

  • 按产品
    • 辅助人工心臟
    • 完全人工心臟
    • 主动脉内球囊反搏泵
  • 依类型
    • 透皮
    • 安装
  • 依治疗方法
    • BTT
    • 比特币
    • DT
  • 按最终用户
    • 医院
    • 心臟中心
    • 门诊手术中心
  • 按地区
    • 北美心臟辅助设备市场规模（2021-2030 年）
    • 欧洲心臟辅助设备市场规模（2021-2030 年）
    • 亚太地区心臟辅助设备市场规模（2021-2030 年）
    • 其他地区心臟辅助设备市场规模（2021-2030）

第七章心臟辅助装置公司及产品简介

  • Abbott Laboratories
  • Abiomed, Inc.
  • Teleflex Incorporated
  • SynCardia Systems, LLC
  • St. Jude Medical Inc.
  • Berlin Heart
  • CARMAT
  • CorWave SA
  • Medtronic Inc.
  • Terumo Heart, Inc.
  • Balton Ltd.
  • NovaPump GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Thoratec Corporation
  • Getinge AB

第8章KOL浏览量

第 9 章专案方法

第10章DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0053

Cardiac Assist Devices Market By Product (Ventricular Assist Devices [Left Ventricular Assist Devices (LVAD), Biventricular Ventricular Assist Devices (BIVAD), and Right Ventricular Assist Devices (RVAD)], Artificial Heart, and Intra-Aortic Balloon Pump), Type (Transcutaneous and Implantable), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, and Bridge-To-Candidacy (BTC Therapy), End-User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to growth in new therapies and increasing prevalence of coronary diseases.

The global cardiac assist devices market was valued at USD 2.89 billion in 2023, growing at a CAGR of 13.70% during the forecast period from 2024 to 2030, to reach USD 6.23 billion by 2030. The demand for cardiac assistance devices is motivated by a rise in the prevalence of coronary diseases, growth in new therapies, the affordability of medical devices, increasing penetration and acceptance of cardiac assistance devices in emerging countries, and innovation and advancement of medical devices.

Cardiac Assist Devices Market Dynamics:

Heart transplantation is widely regarded as the greatest therapeutic option for individuals with end-stage heart failure across the world. Only a limited percentage of patients get transplants due to the scarcity of organs available for transplantation. According to the most recent statistics, the number of patients waiting for a heart transplant has more than doubled in only five years. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of cardiac assist.

Cardiac Assist Devices (CAD) are a type of mechanical pump that operate together with the heart to increase the effectiveness of pumping and maintain optimal blood flow across the body. To treat end-stage heart failure, cardiac aid systems are used that are determined by the individual's needs. As a result of the scarcity of cardiac donors, temporary cardiac assist devices are utilized to provide long-term assistance for individuals.

According to a report from the American Heart Association, 2020, the prevalence of heart failure continues to increase over time, with the aging of the population. It is predicted that the rising number of elderly patients would transform healthcare delivery and create a larger demand for cardiac assist devices. As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure for such patients is expected to double and reach 1.5 billion by 2050. Since the aging population is more prone to cardiovascular disorders, therefore it will give rise to more demand for cardiac assist devices, which will boost the cardiac assist devices market.

Moreover, companies are increasing their manufacturing of essential medical device products. For instance, in August 2022, the United States Food and Drug Administration (FDA) granted breakthrough device designation to Abiomed's Impella ECP expandable percutaneous heart pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes including design iterations, clinical study protocols, and pre-market approval (PMA) application.

Therefore, such initiatives are expected to help the market and the patients in their treatment which will drive the cardiac assist devices market growth also.

However, high treatment costs and limitations regarding the safety of implantable devices may prove to be certain restraints to the Cardiac Assist Devices market growth.

Cardiac Assist Devices Market Segment Analysis:

Cardiac Assist Devices Market By Product (Ventricular Assist Devices [Left Ventricular Assist Devices (LVAD), Biventricular Ventricular Assist Devices (BIVAD), and Right Ventricular Assist Devices (RVAD)], Artificial Heart, and Intra-Aortic Balloon Pump), Type (Transcutaneous and Implantable), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, and Bridge-To-Candidacy (BTC Therapy), End-User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the cardiac assist devices market product segment under the ventricular assist devices category, left ventricular assist devices are expected to hold a significant share during the forecast period. It is primarily attributed to the advantages and applications associated with LVAD coupled with increasing technological advancements, the scarcity of organ donors, and the increasing prevalence of heart failure globally.

LVAD is intended for the treatment of patients with severe heart failure by restoring normal blood flow. The implantation of LVAD in heart failure patients can be life-saving and buys more time for them till organ transplantation.

LVADs are highly reliable and come with built-in safety systems.

Post implantation of LVAD, patients witness improvement in their health and can return/resume their daily activities including driving, and others.

LVADs offer intermediate to long-term treatment solutions for severe heart failure patients. Additionally, assistance from government bodies, and favorable reimbursement scenarios, are expected to enhance the cardiac assist devices market potential in several countries.

Hence, all the above-mentioned factors are expected to drive the segment growth.

North America is expected to dominate the Overall Cardiac Assist Devices Market:

Among all the regions, North America is expected to account for the largest share of the cardiac assist devices market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major cardiac assist devices market players in the region are predicted to be the major influencing factors in driving the overall growth of the cardiac assist devices market over the forecast period.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020. Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

As per the facts provided by the CDC 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.

In addition, the well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encourages people to opt for such devices.

Thereby, considering the presence of a large patient pool in the US coupled with new product launches, the market for cardiac assist devices looks promising in the United States.

Cardiac Assist Devices Market Key Players:

Some of the key market players operating in the cardiac assist devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.

Recent Developmental Activities in the Cardiac Assist Devices Market:

In December 2020, Abbott received FDA approval for the updated labeling for the HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.

In March 2020, the US-based healthcare giant, SynCardia Systems LLC, got approval from the US FDA for a 50CC temporary total artificial heart system as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.

Key Takeaways from the Cardiac Assist Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global cardiac assist devices market.

Various opportunities are available for the other competitor in the cardiac assist devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for cardiac assist devices market growth in the coming future?

Target Audience who can be benefited from this Cardiac Assist Devices Market Report Study

Cardiac Assist Devices providers

Research organizations and consulting companies

Cardiac Assist Devices related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in cardiac assist devices

Various End-users want to know more about the cardiac assist devices market and the latest technological developments in the cardiac assist devices market.

Frequently Asked Questions for Cardiac Assist Devices Market:

1. What are Cardiac Assist Devices?

Cardiac Assist Devices (CAD) are a type of mechanical pump that operate together with the heart to increase the effectiveness of pumping and maintain optimal blood flow across the body. To treat end-stage heart failure, cardiac aid systems are used that are determined by the individual's needs. As a result of the scarcity of cardiac donors, temporary cardiac assist devices are utilized to provide long-term assistance for individuals.

2. What is the market for global cardiac assist devices?

The global cardiac assist devices market was valued at USD 2.89 billion in 2023, growing at a CAGR of 13.70% during the forecast period from 2024 to 2030, to reach USD 6.23 billion by 2030.

3. What are the drivers for global cardiac assist devices?

The major drivers driving the demand for cardiac assist devices are a rise in the prevalence of coronary diseases, growth in new therapies, the affordability of medical devices, increasing penetration and acceptance of cardiac assistance devices in emerging countries, and innovation and advancement of medical devices.

4. Who are the key players operating in global cardiac assist devices?

Some of the key market players operating in the cardiac assist devices market include Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, Inc., NovaPump GmbH, Getinge AB, Balton Ltd., Meril Life Sciences Pvt. Ltd., Thoratec Corporation, CardiacAssist, Inc., Berlin Heart GmbH, and others.

5. Which region has the highest share in the cardiac assist devices market?

North America is expected to dominate the overall cardiac assist devices market during the forecast period, 2024 to 2030. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major cardiac assist devices market players in the region.

Table of Contents

1. Cardiac Assist Devices Market Report Introduction

2. Cardiac Assist Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Cardiac Assist Devices Market Key Factors Analysis

  • 4.1. Cardiac Assist Devices Market Drivers
    • 4.1.1. Rise in prevalence of coronary diseases
    • 4.1.2. Growth in new therapies
    • 4.1.3. Scarcity of heart donors
  • 4.2. Cardiac Assist Devices Market Restraints and Challenges
    • 4.2.1. High cost of the pump
    • 4.2.2. Low repayment scenario in developing countries
  • 4.3. Cardiac Assist Devices Market Opportunities
    • 4.3.1. Increasing penetration and acceptance of cardiac assistance devices
    • 4.3.2. Development of non-invasive, compact, and advanced devices

5. Cardiac Assist Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Cardiac Assist Devices Market Layout

  • 6.1. By Product
    • 6.1.1. Ventricular Assist Devices
      • 6.1.1.1. Left Ventricular Assist Devices (LVAD)
      • 6.1.1.2. Biventricular Ventricular Assist Devices (BIVAD)
      • 6.1.1.3. Right Ventricular Assist Devices (RVAD)
    • 6.1.2. Total Artificial Hearts
    • 6.1.3. Intra-Aortic Balloon Pumps
  • 6.2. By Type
    • 6.2.1. Transcutaneous
    • 6.2.2. Implantable
  • 6.3. By Therapy
    • 6.3.1. Bridge-To-Transplant (BTT)
    • 6.3.2. Bridge-To-Candidacy (BTC)
    • 6.3.3. Destination Therapy (DT)
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Cardiac Centers
    • 6.4.3. Ambulatory Surgical Centers
  • 6.5. By Geography
    • 6.5.1. North America Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.1.1. United States Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Cardiac Assist Devices Market Size in USD million (2021-2030)
    • 6.5.2. Europe Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.1. France Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Cardiac Assist Devices Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.1. China Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.3. India Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia Pacific Cardiac Assist Devices Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Cardiac Assist Devices Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Cardiac Assist Devices Market Size in USD million (2021-2030)

7. Cardiac Assist Devices Company and Product Profiles

  • 7.1. Abbott Laboratories
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Abiomed, Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Teleflex Incorporated
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. SynCardia Systems, LLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. St. Jude Medical Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Berlin Heart
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. CARMAT
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. CorWave SA
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medtronic Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Terumo Heart, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Balton Ltd.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. NovaPump GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Meril Life Sciences Pvt. Ltd.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Thoratec Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Getinge AB
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Cardiac Assist Devices Market in Global (2021-2030)
  • Table 3: Cardiac Assist Devices Market in Global by Product (2021-2030)
  • Table 4: Cardiac Assist Devices Market in Global by Type (2021-2030)
  • Table 5: Cardiac Assist Devices Market in Global by Therapy (2021-2030)
  • Table 6: Cardiac Assist Devices Market in Global by End-User (2021-2030)
  • Table 7: Cardiac Assist Devices Market in Global by Geography (2021-2030)
  • Table 8: Cardiac Assist Devices Market in North America (2021-2030)
  • Table 9: Cardiac Assist Devices Market in the US (2021-2030)
  • Table 10: Cardiac Assist Devices Market in Canada (2021-2030)
  • Table 11: Cardiac Assist Devices Market in Mexico (2021-2030)
  • Table 12: Cardiac Assist Devices Market in Europe (2021-202
  • Table 13: Cardiac Assist Devices Market in France (2021-2030)
  • Table 14: Cardiac Assist Devices Market in Germany (2021-2030)
  • Table 15: Cardiac Assist Devices Market in the United Kingdom (2021-2030)
  • Table 16: Cardiac Assist Devices Market in Italy (2021-2030)
  • Table 17: Cardiac Assist Devices Market in Spain (2021-2030)
  • Table 18: Cardiac Assist Devices Market in Rest of Europe (2021-2030)
  • Table 19: Cardiac Assist Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Cardiac Assist Devices Market in China (2021-2030)
  • Table 21: Cardiac Assist Devices Market in Japan (2021-2030)
  • Table 22: Cardiac Assist Devices Market in India (2021-2030)
  • Table 23: Cardiac Assist Devices Market in Australia (2021-2030)
  • Table 24: Cardiac Assist Devices Market in South Korea (2021-2030)
  • Table 25: Cardiac Assist Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Cardiac Assist Devices Market in the Rest of the World (2021-2030)
  • Table 27: Cardiac Assist Devices Market in the Middle East (2021-2030)
  • Table 28: Cardiac Assist Devices Market in Africa (2021-2030)
  • Table 29: Cardiac Assist Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Cardiac Assist Devices Market in Global (2021-2030)
  • Figure 3: Cardiac Assist Devices Market in Global by Product (2021-2030)
  • Figure 4: Cardiac Assist Devices Market in Global by Type (2021-2030)
  • Figure 5: Cardiac Assist Devices Market in Global by Therapy (2021-2030)
  • Figure 6: Cardiac Assist Devices Market in Global by End-User (2021-2030)
  • Figure 7: Cardiac Assist Devices Market in Global by Geography (2021-2030)
  • Figure 8: Cardiac Assist Devices Market in North America (2021-2030)
  • Figure 9: Cardiac Assist Devices Market in the US (2021-2030)
  • Figure 10: Cardiac Assist Devices Market in Canada (2021-2030)
  • Figure 11: Cardiac Assist Devices Market in Mexico (2021-2030)
  • Figure 12: Cardiac Assist Devices Market in Europe (2021-2030)
  • Figure 13: Cardiac Assist Devices Market in France (2021-2030)
  • Figure 14: Cardiac Assist Devices Market in Germany (2021-2030)
  • Figure 15: Cardiac Assist Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Cardiac Assist Devices Market in Italy (2021-2030)
  • Figure 17: Cardiac Assist Devices Market in Spain (2021-2030)
  • Figure 18: Cardiac Assist Devices Market in Rest of Europe (2021-2030)
  • Figure 19: Cardiac Assist Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Cardiac Assist Devices Market in China (2021-2030)
  • Figure 21: Cardiac Assist Devices Market in Japan (2021-2030)
  • Figure 22: Cardiac Assist Devices Market in India (2021-2030)
  • Figure 23: Cardiac Assist Devices Market in Australia (2021-2030)
  • Figure 24: Cardiac Assist Devices Market in South Korea (2021-2030)
  • Figure 25: Cardiac Assist Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Cardiac Assist Devices Market in Rest of the World (2021-2030)
  • Figure 27: Cardiac Assist Devices Market in the Middle East (2021-2030)
  • Figure 28: Cardiac Assist Devices Market in Africa (2021-2030)
  • Figure 29: Cardiac Assist Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis